Reliance Industries To Roll Out Genome Testing Kit Soon: Report

Mukesh Ambani-backed Reliance Industries has forayed into genome testing and its test kit will be rolled out soon. The kit is developed by the Bengaluru-based Strand Life Sciences, which was acquired by Reliance Industries in 2021 and has 80 per cent stake in the firm.
As per a report from Allied Market Research, the market for global genetic testing was valued at $12.7 billion in 2019 and is anticipated to touch $21.3 billion by 2027
Outlook covers the latest India news, analysis, business news and long-form stories on culture, money market and personal finance. Read India's best online magazine.

Biosensors, Free Full-Text

Colon cancer screening kits have high rate of untestable samples

C2CAplus: A One-Pot Isothermal Circle-to-Circle DNA Amplification System

Asia's richest man to enter genetic testing market with $145 kits

Mukesh Ambani's Reliance to roll out genome sequencing kit priced Rs 12,000; all you need to know

Profile of Outlook Business Team

Frontiers Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Feluda paper strip test kit to be available in 8 metro cities: Full list

Reliance's genome test kit to launch soon, costs Rs. 12,000

Profile of Outlook Business Team

2021 Report to Congress: Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program by NICHQ - Issuu

Rolling circle amplification of synthetic DNA accelerates biocatalytic determination of enzyme activity relative to conventional methods

Reliance: Reliance says it will soon offer genomic tests. Here's what you must know about them. - The Economic Times

Latest & Updated Business News from India & World - Live News

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? - eBioMedicine